High-Acuity Services Driving Admissions Growth at Amedisys
Hospice News
JULY 27, 2023
High-acuity care in the home has become an admissions growth engine for Amedisys (NASDAQ: AMED), which the company delivers through its subsidiary Contessa. Combined, hospital-at-home and skilled nursing facility-at-home admissions grew by 55% year-over-year during the second quarter of the year. This is compared to a 4% increase in home health same-store admissions and a 6% decline for its hospice segment.
Let's personalize your content